Active immunotherapy in the treatment of experimental leukemias and acute lymphoblastic leukemia in man.
D000276:Adjuvants, Immunologic; D000293:Adolescent; D000328:Adult; D000818:Animals; D001500:BCG Vaccine; D002648:Child; D002675:Child, Preschool; D003520:Cyclophosphamide / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007167:Immunotherapy; D007939:Leukemia L1210 / Q000628:therapy; D007942:Leukemia, Experimental / Q000628:therapy*; D007945:Leukemia, Lymphoid / Q000628:therapy*; D017710:Lymphocyte Transfusion; D015122:Mercaptopurine / Q000627:therapeutic use; D008727:Methotrexate / Q000627:therapeutic use; D051379:Mice; D008875:Middle Aged; D009368:Neoplasm Transplantation; D011241:Prednisone / Q000627:therapeutic use; D011830:Radiation Effects; D014184:Transplantation, Homologous; D014750:Vincristine / Q000627:therapeutic use
D000276:Adjuvants, Immunologic; D001500:BCG Vaccine; D014750:Vincristine; D003520:Cyclophosphamide; D015122:Mercaptopurine; D011241:Prednisone; D008727:Methotrexate